ACH (Accendra Health) Loans Receivable: $0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACH Accendra Health Inc ACH
59 GF Score
Price $3.61
GF Value $5.45
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Accendra Health Loans Receivable?

Accendra Health ACH +7.12% 59 Loans Receivable is $0 Mil as of Mar. 2026. GuruFocus rates ACH with a GF Score™ of 59/100 and a GF Value™ of $5.45 (Possible Value Trap). The stock has 7 warning signs investors should review.

Accendra Health's Loans Receivable for the quarter that ended in Mar. 2026 was $0 Mil.

Accendra Health Loans Receivable Related Terms

Accendra Health Loans Receivable Historical Data

* Premium members only.

The historical data trend for Accendra Health's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accendra Health Loans Receivable Chart

Accendra Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Accendra Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ACH
59GF Score
Accendra Health Inc ACH
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accendra Health Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of $0 Mil mean?
Accendra Health (ACH) has a Loans Receivable of $0 Mil as of Mar. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Accendra Health and its competitors.
Is Accendra Health's Loans Receivable too high?
Accendra Health's current Loans Receivable is $0 Mil. Overall, Accendra Health has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Loans Receivable compare to FOCL and YI?
Accendra Health's Loans Receivable of $0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Medical Distribution company?
A good Loans Receivable depends on the Medical Distribution industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Accendra Health and its competitors. Accendra Health's current Loans Receivable is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.45, compared to a current price of $3.61 — trading 33.8% below its estimated fair value. The current Loans Receivable is $0 Mil. Accendra Health's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Accendra Health (ACH), the current Loans Receivable is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accendra Health (ACH) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of $3.61 is trading 33.8% below its estimated GF Value™ of $5.45. GuruFocus considers Accendra Health to be Possible Value Trap.

Key valuation signals for ACH:

  • Loans Receivable: $0 Mil
  • GF Value™: $5.45 vs. price of $3.61 (33.8% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Accendra Health Business Description

Other Exchanges 6OM:Germany
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
59GF Score

Get the complete analysis for ACH

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.61
Price
$5.45
GF Value